U.S. Markets open in 6 hrs 46 mins

ADM Tronics Unlimited, Inc. (ADMT)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1499+0.0141 (+10.38%)
At close: 10:19AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1358
Open0.1498
BidN/A x N/A
AskN/A x N/A
Day's Range0.1498 - 0.1499
52 Week Range0.0800 - 0.1800
Volume650
Avg. Volume70,688
Market Cap10.132M
Beta (5Y Monthly)-0.15
PE Ratio (TTM)N/A
EPS (TTM)-0.0030
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Ventis Medical Selects ADM Tronics to Produce New Ventilator Technology
    GlobeNewswire

    Ventis Medical Selects ADM Tronics to Produce New Ventilator Technology

    Northvale, NJ, April 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ADM Tronics Unlimited, Inc. (OTCQB - ADMT) today announced that Ventis Medical, Inc. (“VMI”), has entered into an agreement for ADMT to provide regulatory support and manufacturing for VMI’s next-generation, portable ventilator technology, The Ventis VM-2000 Ventilator. VMI was founded under the clinical guidance of Glenn W. Laub, MD, a cardiac surgeon and medical technology developer who recognized the need for a low-cost, simple-to-use ventilator based on his experiences witnessing certain patients critically deteriorate while waiting for a ventilator to be applied, as well as ventilation being delayed in emergency scenarios due to the complexity of deploying standard ventilators. After completing extensive development efforts and qualifications of the Ventis VM-2000 Ventilator, VMI sought an FDA-Registered and ISO-13485 certified medical device manufacturer to bring the device into production. After reviewing potential companies, VMI selected ADMT. Karen Laub, VMI President, stated, “We are pleased to be working with ADM Tronics to bring our Ventis VM-2000 Ventilator into volume production. There is a significant need for a low-cost, easy-to-use ventilator for emergency use with improved functionality. We believe the VM-2000 fills that need, and I am confident ADMT can help us to produce it for the marketplace.”ADMT will meet regulatory requirements for quantity manufacturing of the Ventis Ventilator in ADMT’s FDA-Registered Medical Device Manufacturing Facility in Northvale, NJ. ADMT will support VMI in regulatory manufacturing requirements for US FDA and international distribution. “We are honored and pleased that VMI has chosen our company for this important technology that can help so many people around the world,” stated Andre’ DiMino, President and CEO of ADMT. “Our regulatory and manufacturing teams look forward to working with Dr. Laub and the development team at VMI to bring the Ventis Ventilator into production for the medical marketplace.” Based in Princeton, NJ, VMI’s unique mix of clinical, engineering and product expertise provides the platform for this breakthrough in ventilator technology. The Ventis Ventilator is the only ventilator technology positioned to remove the limitations not only on cost, but also on extensive training in order to deliver lifesaving care where Bag Valve Devices (BVDs) are used today. When ventilators are not available, doctors must resort to BVDs which require an operator to manually squeeze 500mL of air every 5 seconds, or potentially forego lifesaving care. ADMT is excited to partner with Ventis Medical to pursue the mission of expanding access to high quality ventilatory care globally. About ADMT ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Proprietary Medical Devices; Medical Device Design, Engineering, Regulatory and Manufacturing Services; and Eco-Friendly, Water-Based Formulations. The Company’s headquarters, laboratories, FDA-Registered medical device, and manufacturing operations are in Northvale, NJ. ADMT’s multi-disciplinary team of engineers, researchers, and technologists utilize advanced technology infrastructure, such as rapid 3-D prototyping, precision instrumentation and specialized software and peripherals, for research, development, and commercialization of diversified technologies. Additional information is available on the Company’s website - admtronics.com. ADMT welcomes inquiries for its medical device services via the ADMT website – www.admtronics.com. To receive email updates directly from ADMT, fill in the form at the bottom of this page: https://admtronics.com/investor-relations/ Except for historical information contained herein, the matters set forth in this news release are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT’s SEC filings, news releases, and other communications. The Company assumes no obligation to update the information contained in this news release. Andre DiMino201-767-6040andre@admtronics.com

  • ADM Tronics to Participate at Lytham Partners Spring 2021 Investor Conference
    GlobeNewswire

    ADM Tronics to Participate at Lytham Partners Spring 2021 Investor Conference

    Northvale, NJ, March 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ADM Tronics Unlimited, Inc. (OTCQB – ADMT) announced today that it will be participating at the Lytham Partners Spring 2021 Investor Conference. Andre DiMino, President of ADMT, will be available for virtual one-on-one meetings throughout the event, which runs from March 30, 2021 through April 1, 2021. To arrange a meeting, contact Lytham Partners at: 1x1@lythampartners.com or register here: Register (meetmax.com). “We are pleased to participate in this year’s Lytham Partners Investor Spring Conference and for the opportunity to discuss our company’s progress with our innovative medical technologies currently in development,” stated DiMino. ADMT specializes in design, development and manufacturing of diagnostic and therapeutic electronic medical technologies at its FDA-Registered and ISO-13485 Certified Medical Device Manufacturing Facility in Northvale, NJ. ADMT has extensive experience in the development of all FDA classes of medical devices with particular emphasis on electronic therapeutic modalities. The Company has a pipeline of several proprietary medical devices currently in various stages of development. In addition to its own medical technology developments, the Company is a one-stop source for complete design, engineering, regulatory and manufacturing services, specifically related to US and international medical device development. Its capability in bringing a medical device from the conceptual stage, through design, development and regulatory stages into production, all in-house, differentiates ADMT from firms supplying only portions of those services. ADMT welcomes inquiries for its medical device services via the ADMT website – www.admtronics.com. To receive email updates directly from the Company, fill in the form at the bottom of this page: https://admtronics.com/investor-relations/ About ADMT ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Proprietary Medical Devices; Medical Device Design, Engineering, Regulatory and Manufacturing Services; and, Eco-Friendly Formulations from its headquarters, laboratories, and FDA-Registered medical device manufacturing operations. ADMT’s multi-disciplinary team of engineers, researchers, and technologists utilize advanced technology infrastructure for R&D and commercialization of diversified technologies. admtronics.com. Except for historical information contained herein, the matters set forth in this news release are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT’s SEC filings, news releases, and other communications. The Company assumes no obligation to update the information contained in this news release. Press Contact– Andre’ DiMino – 201-767-6040 – andre@admtronics.com

  • ADM Tronics Secures Infectious Disease Prevention Training Certification
    GlobeNewswire

    ADM Tronics Secures Infectious Disease Prevention Training Certification

    Northvale, NJ, Feb. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ADM Tronics Unlimited, Inc. (OTCQB – ADMT) has secured the “Infectious Disease Prevention Training Certification” from the New Jersey Business and Industry Association (“NJBIA”) by creating and formally adopting a disease prevention plan and detailed procedures, meeting guidelines set forth by The World Health Organization, Center for Diseases Control and the Occupational Safety and Health Administration. ADMT participated in workshops and training conducted by NJBIA required to secure the Certification for designation as a “Certified Site.” Throughout the pandemic, ADMT implemented aggressive steps to minimize disruption of operations including having Essential Manufacturer exemption from statewide shutdowns and encompassing safety guidelines in ADMT’s operations. This allowed continued research, development and manufacturing operations throughout the COVID-19 pandemic. “Securing this Certification is another facet of our commitment to minimize the impact of the pandemic on our Company,” stated Andre’ DiMino, President of ADMT. “The health of our employees, their families and our community is paramount, as we continue to exercise caution to help avoid spread of the disease, while at the same time, maintaining our operations. Technologies we develop and manufacture are needed for the medical and other industries we serve. We strive to maintain our ability to produce these for our loyal customers, and the patients and users needing them.” ADMT specializes in design, development and manufacturing of diagnostic and therapeutic electronic medical technologies at its FDA-Registered Medical Device Manufacturing Facility in Northvale, NJ. ADMT has extensive experience in the development of all FDA classes of medical devices with particular emphasis on electronic therapeutic modalities. The Company has a pipeline of several proprietary medical devices currently in various stages of development. In addition to its own medical technology developments, the Company is a one-stop source for complete design, engineering, regulatory and manufacturing services, specifically related to US and international medical device development. Its capability in bringing a medical device from the conceptual stage, through design, development and regulatory stages into production, all in-house, differentiates ADMT from firms supplying only portions of those services. ADMT welcomes inquiries for its medical device services via the ADMT website – www.admtronics.com. To receive email updates directly from the Company, fill in the form at the bottom of the page at this link: https://admtronics.com/investor-relations/ About ADMT ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Proprietary Medical Devices; Medical Device Design, Engineering, Regulatory and Manufacturing Services; and, Eco-Friendly Formulations from its headquarters, laboratories, and FDA-Registered medical device manufacturing operations. ADMT’s multi-disciplinary team of engineers, researchers, and technologists utilize advanced technology infrastructure for R&D and commercialization of diversified technologies. admtronics.com. Except for historical information contained herein, the matters set forth in this news release are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT’s SEC filings, news releases, and other communications. The Company assumes no obligation to update the information contained in this news release. Andre DiMino 201-767-6040 andre@admtronics.com